A Mosaic Activating Mutation inAKT1Associated with the Proteus Syndrome
Author(s) -
Marjorie J. Lindhurst,
Julie C. Sapp,
Jamie K. Teer,
Jennifer J. Johnston,
Erin Finn,
Kathryn F. Peters,
Joyce Turner,
Jennifer L. Cans,
David Bick,
Laurel C. Blakemore,
Catherine Blumhorst,
Knut Brockmann,
Peter Calder,
Natasha Cherman,
Matthew A. Deardorff,
David B. Everman,
Gretchen Golas,
Robert M. Greenstein,
B. Maya Kato,
Kim M. KepplerNoreuil,
Sergei A. Kuznetsov,
Richard T. Miyamoto,
Kurt D. Newman,
David Ng,
Kevin O’Brien,
Steven Rothenberg,
Douglas J. Schwartzentruber,
Virender K. Singhal,
Roberto Tirabosco,
Joseph Upton,
Shlomo Wientroub,
Elaine H. Zackai,
Kimberly Hoag,
Tracey Whitewood-Neal,
Pamela Gehron Robey,
Pamela L. Schwartzberg,
Thomas N. Darling,
Laura L. Tosi,
James C. Mullikin,
Leslie G. Biesecker
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1104017
Subject(s) - proteus syndrome , germline mutation , akt1 , somatic cell , microbiology and biotechnology , mutation , protein kinase b , biology , mutant , cancer research , phosphorylation , genetics , gene
The Proteus syndrome is characterized by the overgrowth of skin, connective tissue, brain, and other tissues. It has been hypothesized that the syndrome is caused by somatic mosaicism for a mutation that is lethal in the nonmosaic state.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom